Local hypoxia is produced at sites of intratumour injection.
Intratumour injection, commonly used for gene or drug delivery but also associated with needle biopsy or insertion of invasive measuring devices, may damage tumour microvessels. To examine this possibility, SCCVII tumours grown subcutaneously in C3H mice were injected with a 26 gauge needle containing 0.1 ml of the fluorescent dye Hoechst 33342 to label cells lining the track of the needle. Hoechst-labelled cells sorted from these tumours were more sensitive to killing by hypoxic cell cytotoxins (tirapazamine, RSU-1069) and less sensitive to damage by ionizing radiation. Hoechst-labelled cells also bound the hypoxia marker pimonidazole when given by i.p. injection. Intratumour injection transiently increased hypoxia from 18 to 70% in the tumour cells adjacent to the track of the needle. The half-time for return to pre-treatment oxygenation was about 30 min; oxygenation of tumour cells along the track had recovered by 20 h after intratumour injection. This effect could have significant implications for intratumour injection of drugs, cytokines or vectors that are affected by the oxygenation status of the tumour cells as well as potential effects on biodistribution via local microvasculature.
Olive
P L
PL
Medical Biophysics Department, British Columbia Cancer Research Centre, 601 W 10th Avenue, Vancouver, BC, V5Z 1L3 Canada. polive@bccancer.bc.ca
Luo
C-M
CM
Banáth
J P
JP
D000818:Animals; D001562:Benzimidazoles / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000235:genetics / Q000473:pathology*; D015687:Cell Hypoxia / Q000502:physiology*; D020552:Comet Assay; D004249:DNA Damage; D006801:Humans; D007267:Injections; D051379:Mice; D009593:Nitroimidazoles / Q000493:pharmacokinetics; D011838:Radiation-Sensitizing Agents / Q000008:administration & dosage / Q000493:pharmacokinetics
D001562:Benzimidazoles; D009593:Nitroimidazoles; D011838:Radiation-Sensitizing Agents; C033815:pimonidazole; C017807:bisbenzimide ethoxide trihydrochloride